Researchers sought to assess whether hospitalizations with infection are associated with dementia incidence.
Researchers assessed the influence of SARS-CoV-2 vaccination timing following rituximab treatment on the incidence of hospitalization and death related to COVID-19 in patients with MS.
Researchers examined the relationship between the pancreatic microbiome and patient characteristics as well as the duodenal microbiome.
Researchers evaluate whether antibiotic use in patients with decompensated cirrhosis and without infection prevented hospital-acquired infection.
Researchers assessed the impact of infliximab and vedolizumab treatments on COVID-19 infection and vaccination in patients with IBD aged 5 years or older.
Researchers assessed data on the safety and efficacy of molnupiravir and nirmatrelvir/ritonavir among patients with systemic autoimmune rheumatic diseases.
Researchers sought to determine the range and frequency of complications of influenza infection in patients with SCN1A-positive Dravet syndrome.
Researchers assessed gene expression patterns in the brains of patients with COVID-19 and compared them with changes seen in the brains of individuals not infected with the virus.
Researchers evaluated outcomes among patients hospitalized with COVID-19 infection who received extracorporeal membrane oxygenation during the first COVID-19 wave.
Researchers sought to analyze COVID-19 vaccination status among parents of hospitalized children younger than age 5 years with COVID-19 infection during the Delta and Omicron waves.
Researchers evaluated adverse events following COVID-19 vaccination among previously infected individuals compared with those with no COVID-19 history.
Researchers compared the clinical presentation of Lyme disease among children by race/ethnicity.
The tools used in an adolescent transition program to aide patients with HIV infection transition to independent care were evaluated for effectiveness.
Researchers estimated Medicaid spending on antiretroviral medications to treat HIV from 2007 to 2019.
The prevalence and outcomes of gout flares were studied among patients with comorbid gout hospitalized for COVID-19.
Researchers evaluated the antiviral efficacy of molnupiravir among vaccinated and unvaccinated patients infected with a broad range of COVID-19 variants.
Researchers assessed the rate and risk for COVID-19 breakthrough infection among patients with vs without HIV infection.
Researchers evaluated self-reported rates of stigma and health care-associated discrimination among Hispanic individuals with HIV infection.
The adverse events related to COVID-19 vaccination were evaluated among patients with rheumatoid arthritis.
Researchers evaluated the effect of gender on the clinical presentation of tuberculosis and the risk for tuberculosis and HIV coinfection.
Researchers assessed the effects of switching to low-dose linezolid among patients with multidrug-resistant tuberculosis infection.
Researchers sought to assess the association of sleep duration with chronic disease, subsequent multimorbidity, and mortality at ages 50, 60, and 70 years.
Researchers compared dual therapy using vonoprazan and amoxicillin with triple therapy using vonoprazan, amoxicillin, and clarithromycin to eradicate H pylori.
Researchers evaluated the effect of beliefs about antibiotic treatment outcomes among patients with appendicitis.
Researchers evaluated the diagnostic accuracy of rapid diagnostic tests for Ebola virus disease.
Researchers examined whether patients with IBD receiving immunosuppressive treatment had a reduced immune response after a third COVID-19 vaccine dose.
Researchers evaluated outcomes among children hospitalized with influenza who received early treatment with oseltamivir.
Researchers evaluated human papillomavirus vaccination rates per patient encounter in the period before and during the COVID-19 pandemic.
In a prospective, multicenter, observational cohort study, researchers evaluated the response of patients with neuromuscular disorders to the BNT162b2 (BioNTech, Pfizer) COVID-19 vaccine.
Presenting at ACG 2022, researchers evaluated the efficacy and safety of RBX2660 in the treatment of recurrent C difficile infections.
